Department of Clinical Sciences

Medicine & Life Sciences

1. HIV 100%
2. Belgium 39%
3. Malaria 39%
4. Democratic Republic of the Congo 37%
5. Ethiopia 34%
6. Visceral Leishmaniasis 32%
7. Routine Diagnostic Tests 30%
8. Tuberculosis 30%
9. Uganda 28%
10. Therapeutics 27%
11. Cambodia 24%
12. Infection 24%
13. Sexually Transmitted Diseases 20%
14. HIV Infections 19%
15. Africa South of the Sahara 17%
16. HIV-1 16%
17. Coinfection 14%
18. Syphilis 14%
19. Bacterial Vaginosis 13%
20. Virus Diseases 13%
21. Rwanda 13%
22. Guinea 12%
23. Neisseria gonorrhoeae 12%
24. South Africa 12%
25. Population 12%
26. Disease Outbreaks 12%
27. Acquired Immunodeficiency Syndrome 12%
28. Cross-Sectional Studies 12%
29. CD4 Lymphocyte Count 12%
30. Parasites 12%
31. Immune Reconstitution Inflammatory Syndrome 11%
32. Cohort Studies 11%
33. Fever 11%
34. Polymerase Chain Reaction 11%
35. Retrospective Studies 11%
36. Microscopy 10%
37. Antigens 10%
38. Gonorrhea 10%
39. Mortality 9%
40. Plasmodium falciparum 9%
41. Ebola Hemorrhagic Fever 9%
42. Kenya 9%
43. Confidence Intervals 9%
44. Burkina Faso 9%
45. Health 8%
46. Research 8%
47. Incidence 8%
48. African Trypanosomiasis 8%
49. Antibodies 8%
50. Viral Load 7%
51. Microbiota 7%
52. Guidelines 7%
53. Enzyme-Linked Immunosorbent Assay 7%
54. Western Africa 7%
55. Salmonella typhi 7%
56. Pharmaceutical Preparations 7%
57. Eastern Africa 7%
58. HIV-2 7%
59. Anti-Bacterial Agents 7%
60. Tenofovir 7%
61. Clinical Trials 7%
62. Treatment Failure 7%
63. Azithromycin 7%
64. Schistosomiasis 7%
65. Sexual Behavior 7%
66. Point-of-Care Systems 7%
67. Genotype 6%
68. Treponema pallidum 6%
69. Delivery of Health Care 6%
70. Multidrug-Resistant Tuberculosis 6%
71. Chikungunya virus 6%
72. Plasmodium 6%
73. Safety 6%
74. Salmonella 6%
75. Ciprofloxacin 6%
76. Viruses 6%
77. Peru 6%
78. Macrolides 6%
79. Gambia 6%
80. Sex Workers 5%
81. Health Facilities 5%
82. Serum 5%
83. Rifampin 5%
84. Schistosoma 5%
85. Tanzania 5%
86. Chlamydia trachomatis 5%
87. Typhoid Fever 5%
88. Referral and Consultation 5%
89. Fluoroquinolones 5%
90. Hepatitis C 5%
91. Sierra Leone 5%
92. Salmonella paratyphi A 5%
93. Falciparum Malaria 5%
94. Gardnerella vaginalis 5%
95. Burkholderia pseudomallei 5%
96. Heterosexuality 5%
97. Zambia 5%
98. Real-Time Polymerase Chain Reaction 5%
99. T-Lymphocytes 5%
100. Odds Ratio 5%